Methylation analysis of the gene ADRB2
ADRB2基因甲基化分析
基本信息
- 批准号:7588589
- 负责人:
- 金额:$ 7.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-06-19 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:ADRB2 geneAgonistAsthmaBindingCandidate Disease GeneCell ProliferationCellsChronic Obstructive Airway DiseaseCodeDNADNA MethylationDataEpigenetic ProcessFutureGene ExpressionGene Expression RegulationGene ProteinsGenesGeneticGenetic PolymorphismGenotypeHealthHumanIncubatedInvestigationMeasuresMessenger RNAMethylationMonitorObstructive Lung DiseasesPatternPharmacogeneticsPilot ProjectsProliferatingProteinsReverse Transcriptase Polymerase Chain ReactionRoleSiteSmooth Muscle MyocytesTachyphylaxisTestingTimebasecell typeexposed human populationfield studypromoterprotein expressionradioligandreceptorreceptor expressionresearch studyrespiratory smooth muscleresponse
项目摘要
Epigenetic regulation of gene expression is an emerging concept relevant to human health. This proposal's objective is to investigate the epigenetic control of ADRI32 expression in cells relevant to obstructive lung
.=.
�'m
exposed to a a-agonist, the degree of DNA methylation is increased in the promoter and coding region of the gene for the 13-agonist receptor, ADRB2. Based on the classical function that DNA methylation blocks or decreases gene expression, we hypothesize that long term exposure of HASM cells to 13-agonist increases methylation of ADRB2 and resulting in decreased expression of ADRB2. This decrease in ADR132 could be a major mechanism contributing to tachyphylaxis to 13-agonist treatment in asthma and COPD. In this proposed pilot study, we will test our hypothesis by: 1) Performing methylation specific sequencing on ADRI32 to localize and quantitate methylated CpG sites in DNA isolated from HASM cells exposed to 13-agonists; 2) Assessing the effects of ADR2 methylation on gene expression.
v+3
�:3
W-0
=:r
a:'
�--,
any
0-0
disease. We have recent preliminary data showing that in human airway smooth muscle (HASM) cells
U).2
M-0
.4)
`Z-_
Gam.
pro.
-0a�
>,Q
tom/!
a--
基因表达的表观遗传调控是一个与人类健康相关的新兴概念。本研究的目的是研究ADRI32在阻塞性肺相关细胞中表达的表观遗传控制
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GREGORY A HAWKINS其他文献
GREGORY A HAWKINS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GREGORY A HAWKINS', 18)}}的其他基金
A novel, genetic model of IL-6 trans-signaling to interrogate cardiac fibrosis pathology
用于研究心脏纤维化病理学的新型 IL-6 信号转导遗传模型
- 批准号:
10667223 - 财政年份:2023
- 资助金额:
$ 7.4万 - 项目类别:
Perkin Elmer Sciclone G3 NGSx Workstation for High Throughput Sequencing Library Preparation
Perkin Elmer Sciclone G3 NGSx 工作站用于高通量测序文库制备
- 批准号:
9272640 - 财政年份:2017
- 资助金额:
$ 7.4万 - 项目类别:
Severe Asthma and the Glucocorticoid Receptor Complex
严重哮喘和糖皮质激素受体复合物
- 批准号:
7050198 - 财政年份:2005
- 资助金额:
$ 7.4万 - 项目类别:
Severe Asthma and the Glucocorticoid Receptor Complex
严重哮喘和糖皮质激素受体复合物
- 批准号:
6927625 - 财政年份:2005
- 资助金额:
$ 7.4万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Effects of Rare Variants and Ancestry on Beta Agonist Response in Asthma and COPD
罕见变异和血统对哮喘和慢性阻塞性肺病 (COPD) β 受体激动剂反应的影响
- 批准号:
10533637 - 财政年份:2021
- 资助金额:
$ 7.4万 - 项目类别:
Effects of Rare Variants and Ancestry on Beta Agonist Response in Asthma and COPD
罕见变异和血统对哮喘和慢性阻塞性肺病 (COPD) β 受体激动剂反应的影响
- 批准号:
10620284 - 财政年份:2021
- 资助金额:
$ 7.4万 - 项目类别:
Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma
胰高血糖素样肽 1 受体激动剂治疗成人肥胖相关症状性哮喘
- 批准号:
10398799 - 财政年份:2021
- 资助金额:
$ 7.4万 - 项目类别:
Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma
胰高血糖素样肽 1 受体激动剂治疗成人肥胖相关症状性哮喘
- 批准号:
10084583 - 财政年份:2021
- 资助金额:
$ 7.4万 - 项目类别:
Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma
胰高血糖素样肽 1 受体激动剂治疗成人肥胖相关症状性哮喘
- 批准号:
10609049 - 财政年份:2021
- 资助金额:
$ 7.4万 - 项目类别:
Effects of Rare Variants and Ancestry on Beta Agonist Response in Asthma and COPD
罕见变异和血统对哮喘和慢性阻塞性肺病 (COPD) β 受体激动剂反应的影响
- 批准号:
10078976 - 财政年份:2019
- 资助金额:
$ 7.4万 - 项目类别:
Molecular mechanisms underlying the clinical efficacy of inhaled corticosteroid/long-acting beta2-adrenoceptor agonist combination therapies in asthma
吸入皮质类固醇/长效β2-肾上腺素受体激动剂联合疗法治疗哮喘临床疗效的分子机制
- 批准号:
369425 - 财政年份:2017
- 资助金额:
$ 7.4万 - 项目类别:
Operating Grants
Molecular mechanisms underlying the enhanced efficacy of inhaled corticosteroid/long-acting beta2-adrenoceptor agonist combinations used in asthma
吸入皮质类固醇/长效β2-肾上腺素受体激动剂组合增强哮喘疗效的分子机制
- 批准号:
366550 - 财政年份:2016
- 资助金额:
$ 7.4万 - 项目类别:
Operating Grants
Effects of Rare Variants and Ancestry on Beta Agonist Response In Asthma
罕见变异和祖先对哮喘β受体激动剂反应的影响
- 批准号:
9098841 - 财政年份:2015
- 资助金额:
$ 7.4万 - 项目类别:
Effects of Rare Variants and Ancestry on Beta Agonist Response In Asthma
罕见变异和祖先对哮喘β受体激动剂反应的影响
- 批准号:
8968045 - 财政年份:2015
- 资助金额:
$ 7.4万 - 项目类别: